Cardura XL recall: Impurity Out of Spec
Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-079-93
Why was Cardura XL recalled?
Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # 8181625, Exp 12/31/2025
- Product
- Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-079-93
- Recalling firm
- Viatris Inc
- Quantity
- 1,215/30 count bottles
- Distribution
- USA nationwide.
- Recall date
- January 22, 2025
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)